Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms, Castration-Resistant × darolutamide × Clear all

NCT05997615 2026-06-04

AMX-500

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT06190899 2026-04-13

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT05519449 2026-01-20

ENGAGER-PSMA-01

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04157088 2023-08-04

DaroAcT

Phase 2 Terminated

30 enrolled 25 charts

Prostatic Neoplasms, Castration-Resistant